Stock 603669 LIONCO PHARMACEUTICAL GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Lionco Pharmaceutical Group Co.,Ltd.

Equities

603669

CNE1000022R8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
4.73 CNY +2.16% Intraday chart for Lionco Pharmaceutical Group Co.,Ltd. +19.14% -14.47%
Apr. 19 Lionco Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jan. 31 Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023. CI

Business Summary

Lionco Pharmaceutical Group Co.,Ltd. is a China-based company principally engaged in the research and development, production and sales of chemical prescription medicine. The Company's products are mainly categorized in to three areas: parenteral nutrition agents, anti-infectious agents and digestive system agents. The lead product of its parenteral nutrition agents is Glutamine for injection; its anti-infectious agents include Cefodizime sodium for injection and Cefathiamidine for injection, among others; its digestive system agents include Omeprazole Sodium for injection and others. The Company operates its business in domestic market.

Number of employees: 475

Sales per Business

CNY in Million2022Weight2023Weight Delta
Anti-infective
50.1 %
74 25.5 % 99 50.1 % +33.62%
Others
23.4 %
89 30.7 % 46 23.4 % -48.23%
Parenteral Nutrition
17.1 %
84 28.9 % 34 17.1 % -59.65%
Digestive System
5.6 %
36 12.3 % 11 5.6 % -69.05%
Other Business
3.8 %
7 2.6 % 8 3.8 % +0.62%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
289 100.0 % 197 100.0 % -31.95%

Managers

Managers TitleAgeSince
Ling Ping Tao CEO
 Chief Executive Officer 53 03-12-23
Jun Ke Zhang DFI
 Director of Finance/CFO 38 16-12-31
Yan Chen BRD
 Director/Board Member 46 07-03-31
Xiao Gang Tao BRD
 Director/Board Member 48 15-12-13
Bao Yu Liao IRC
 Investor Relations Contact - -
Hong Sheng Wang PRN
 Corporate Officer/Principal 57 10-12-31

Members of the board

Members of the board TitleAgeSince
Zi Qiang Pan BRD
 Director/Board Member 59 19-02-27
Ling Ping Tao CEO
 Chief Executive Officer 53 03-12-23
Xiao Gang Tao BRD
 Director/Board Member 48 15-12-13
Hui Zhang BRD
 Director/Board Member 59 12-09-30
Hong Sheng Wang PRN
 Corporate Officer/Principal 57 10-12-31
Yan Chen BRD
 Director/Board Member 46 07-03-31
Chao He BRD
 Director/Board Member 65 19-02-27
Qian He BRD
 Director/Board Member 52 13-11-30
Dong Yang CHM
 Chairman 46 18-04-18
Bi Yu Zou BRD
 Director/Board Member 34 22-03-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 721,238,653 260,653,422 ( 36.14 %) 3,620,000 ( 0.5019 %) 36.14 %

Shareholders

NameEquities%Valuation
Ling Ping Tao
53.77 %
387,810,000 53.77 % 215 M ¥
Zhong Ou Asset Management Co., Ltd
0.2053 %
1,480,600 0.2053 % 821 481 ¥
China Asset Management Co., Ltd.
0.0782 %
563,829 0.0782 % 312 829 ¥
CICC Fund Management Ltd.
0.000299 %
2,156 0.000299 % 1 196 ¥

Company contact information

Lionco Pharmaceutical Group Co., Ltd.

1/F, Commercial Building 2 No. 68 Naidong Road

856000, Shannan

+86 89 8783 0666

http://www.lingkang.com.cn
address Lionco Pharmaceutical Group Co.,Ltd.(603669)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sector Generic Pharmaceuticals

1st Jan change Capi.
LIONCO PHARMACEUTICAL GROUP CO.,LTD. Stock Lionco Pharmaceutical Group Co.,Ltd.
-14.47% 460M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.98% 43.67B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.51B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.97% 14.6B
CIPLA LIMITED Stock Cipla Limited
+14.32% 13.74B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.72% 11.91B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.04B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.21% 5.42B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603669 Stock
  4. Company Lionco Pharmaceutical Group Co.,Ltd.